🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
We are doing this study to learn more about how tirzepatide may help fight ...
Status
Active Not Recruiting
Location
Valley Clinical Trials, Inc.
Start Date
2023-02-08
Trial ID
NCT05536804
Treatments Being Tested
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
This phase II trial studies the effect of belinostat and SGI-110 (guadecita...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2020-09-08
Trial ID
NCT04340843
This randomized phase III trial studies how well gemcitabine hydrochloride ...
Status
Terminated
Location
Tennessee Valley Gynecologic Oncology
Start Date
2012-06-04
Trial ID
NCT01533207
Cushing's syndrome (CS) and acromegaly determine myopathy and muscle weakne...
Status
Unknown
Location
Hospital de la Santa Creu i Sant Pau
Start Date
2018-02-01
Trial ID
NCT03673761
Treatments Being Tested
This study is to evaluate the sensitivity and intra-/inter-observer agreeme...
Status
Recruiting
Location
University Hospital Basel, Department of Neurology
Start Date
2022-07-18
Trial ID
NCT04819737
Treatments Being Tested
This phase Ib trial will investigate the effect of N-803 in combination wit...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-02-15
Trial ID
NCT07217496
This is an open-label, non-randomised, phase II study to evaluate the effic...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-11-24
Trial ID
NCT04856475
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-03
Trial ID
NCT02721966
Treatments Being Tested
This phase I trial studies the side effects and best dose of pacritinib whe...
Status
Not Yet Recruiting
Location
Roswell Park Comprehensive Cancer Center
Start Date
2026-09-01
Trial ID
NCT07679334